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Background: L-Arginine is a nutritional supplement that may be useful for promoting intestinal repair.
Arginine is metabolised by the oxidative deiminase pathway to form nitric oxide (NO) and by the arginase
pathway to yield ornithine and polyamines.
Aims: To determine if arginine stimulates restitution via activation of NO synthesis and/or polyamine
synthesis.
Methods: We determined the effects of arginine on cultured intestinal cell migration, NO production,
polyamine levels, and activation of focal adhesion kinase, a key mediator of cell migration.
Results: Arginine increased the rate of cell migration in a dose dependent biphasic manner, and was
additive with bovine serum concentrate (BSC). Arginine and an NO donor activated focal adhesion kinase
(a tyrosine kinase which localises to cell matrix contacts and mediates b1 integrin signalling) after
wounding. Arginine stimulated cell migration was dependent on focal adhesion kinase (FAK) signalling, as
demonstrated using adenovirus mediated transfection with a kinase negative mutant of FAK. Arginine
stimulated migration was dependent on NO production and was blocked by NO synthase inhibitors.
Arginine dependent migration required synthesis of polyamines but elevating extracellular arginine
concentration above 0.4 mM did not enhance cellular polyamine levels.
Conclusions: These results showed that L-arginine stimulates cell migration through NO and FAK
dependent pathways and that combination therapy with arginine and BSC may enhance intestinal
restitution via separate and convergent pathways.
A
fter acute mucosal injury, rapid restoration of epithelial
continuity depends on migration of uninjured epithe-
lial cells to cover denuded sections of basement
membrane.1 Enterocyte migration is a mitosis independent
process that is completed within 6–12 hours. Cell adhesion
and migration are mediated by key cytoskeletal and signal-
ling proteins that are organised in lamellipodial extensions.2
At these focal adhesions, numerous proteins colocalise, includ-
ing p120 focal adhesion kinase (FAK),3 talin, alpha-actinin,
vinculin, paxillin, p130Cas, and p60c-src. Several of these
proteins are phosphorylated and activated by FAK.4–8
Arginine (ARG) has been reported to lessen intestinal
damage in animal models of necrotising enterocolitis.9–11 ARG
is metabolised by two major pathways in enterocytes:
conversion by arginase to ornithine, the precursor of poly-
amines, and conversion by nitric oxide synthase (NOS) to nitric
oxide (NO) and citrulline. Polyamines are polycations that
are required for normal formation of lamellipodia and stress
fibres during cell migration. NO is a lipophilic free radical
that stimulates mucus secretion and water absorption,
produces smooth muscle relaxation, and regulates bowel
permeability.12 13 In the current studies, we determined the
effect of ARG on enterocyte migration through FAK
phosphorylation after wounding of cultured cells14 as a first
step in intestinal repair. Bovine serum concentrate (BSC) was
used as a positive control. BSC has been shown by our group
to facilitate intestinal villous regrowth and improve bowel
permeability in experimental cryptosporidial diarrhoea,15 and
serum activates ornithine decarboxylase (ODC) in intestinal
cells.16 BSC is inexpensive and approved by the United States
Department of Agriculture for use as a dietary supplement
(Immunolin or NutraGammax; Proliant Inc., Ames, Iowa,
USA) in health food stores. BSC contains active IgG, IgM,
and IgA, transforming growth factor b (TGF-b), and insulin-
like growth factor 1 (IGF-1).
METHODS
Chemicals
Acrylamide and bisacrylamide were from National
Diagnostics (Atlanta, Georgia, USA). Protease and phospha-
tase inhibitors (aprotinin, leupeptin, bestatin, 4-nitrophenyl
phosphate, pepstatin, dithiothreitol, and NP-40) were from
Boehringer Mannheim (Indianapolis, Indiana, USA).
Herbimycin was from Gibco BRL (Gaithersburg, Maryland,
USA). Tyrphostins (AG213 and 216) were from Professor
Alex Levitski (Hebrew University, Jerusalem, Israel). BSC
was obtained from Proliant Inc. (Ames, Iowa, USA). BSC
powder contains approximately 80% protein, of which 60% is
albumin and 25% is immunoglobulin G (IgG). The manu-
facturer has measured significant levels of IGF-I (6000 ng/g
protein) and TGF-b1 (90 ng/g) in BSC. All other chemicals,
including 3,3-bis(aminoethyl)-1-hydroxy-2-oxo-1-triazene
(Deta-NONOate), were obtained from Sigma (St Louis,
Missouri, USA).
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Abbreviations: ARG, L-arginine; BSC, bovine serum concentrate;
DFMO, difluoromethyl-ornithine; Deta-NONOate, 3,3-bis(aminoethyl)-
1-hydroxy-2-oxo-1-triazene; DMEM, Dulbecco’s modified Eagle’s
medium; FAK, focal adhesion kinase; FBS, fetal bovine serum; iNOS,
inducible nitric oxide synthase; IGF-1, insulin-like growth factor 1; L-Nil,
L-N6(1-iminoethyl)lysine; NEC, necrotising enterocolitis; NMMA, L-NG-
monomethyl arginine; NO, nitric oxide; NOS, nitric oxide synthase;
ODC, ornithine decarboxylase; PBS, phosphate buffered saline; PUT,
putrescine; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel




Mouse monoclonal antibody IgG1 to FAK (clone 4.47) was
obtained from Upstate Biotechnology (Lake Placid, New
Jersey, USA). Mouse monoclonal antiphosphotyrosine (PY-
20) and rabbit polyclonal anti-nitric oxide sythase II (anti-
NOS II) antibodies were obtained from Transduction
Laboratories (Lexington, Kentucky, USA).
Cells
We selected IPEC-J2 cells derived from newborn piglet
jejunum because of their differentiated characteristics,17 and
Cdx2 transformed IEC-6 cells because of a more differen-
tiated phenotype, including a fourfold increased rate of cell
migration.18 19 IPEC-J2 cells were obtained from H
Berschneider (North Carolina State University College of
Veterinary Medicine, Raleigh, North Carolina, USA). IPEC-J2
cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM)/F12 medium with 5% serum, split weekly, and were
studied at passages 28–56. The Cdx2 transformed rat crypt
cell line IEC-618 19 was obtained from Dr J-Y Wang
(University of Maryland, Baltimore, USA). Cdx2 transformed
IEC-6 cells were cultured in DMEM with isopropyl-b-D-
thioguanine (4 mM), which served as the inducer for Cdx2
directed by the LacSwitch system (Stratagene, La Jolla,
California, USA), for four weeks prior to the experiments and
were studied at passages 5–20.
Migration assay
Cells were plated in six well Costar (Corning, New York,
USA) plates. After reaching confluence, cells were serum
starved overnight in DMEM to achieve quiescence. DMEM
contains 0.4 mM ARG. In studies of Cdx2 transformed IEC-6
cells, cells were transferred to amino acid free media for six
hours (BME with Earle’s salts; Atlanta Biologicals, Norcross,
Georgia, USA). Mitomycin C (2 mg/ml) was added.
Preliminary studies showed that mitomycin C fully inhibited
IPEC-J2 cell proliferation at 24 hours. Treatments were
added 15 minutes before razor injuring, and inhibitors (L-
NG-monomethyl arginine (NMMA)20 or difluoromethyl-
ornithine (DFMO), an irreversible inhibitor of ODC) were
added three or 12 hours before treatments, respectively. The
distance at which cells at the leading edge had migrated2 was
measured and expressed as surface area covered by cells (in
mm2) per mm of linear wound.
Measurement of nitrite production
To maximise the number of cells migrating, monolayers were
wounded 20 times with a pipette tip. Media samples were
collected 24 hours later. Production of nitrite, a stable
metabolite of NO, was measured by a Griess reaction assay
kit (G-4410) according to the manufacturer’s instructions
(Sigma).
Intracellular polyamine assay
Twenty four hours after wounding, cells were washed with
phosphate buffered saline (PBS) twice and collected in
polystyrene tubes. Half of the cell pellet was used to measure
total cell protein and half of the pellet was used for
polyamine measurement, as previously described.21 22 For
each 56106 cells, we added 0.2 ml of 1.5 M HClO4. After five
minutes, 0.1 ml of 2 M K2CO3 was added and mixed for
another two minutes. After centrifugation at 3000 g, the
supernatant was stored at 280 C̊ for polyamine measure-
ment. Polyamines were quantified on the basis of standards.
Immunocytochemical staining for iNOS
Cdx2 transformed IEC-6 cells were wounded for 12 hours
and fixed for five minutes at 10 C̊ in methanol. Cells were
treated with 10% goat serum and then incubated with rabbit
anti-iNOS antibodies (Transduction Laboratories) (1:200) for
one hour at 4 C̊. After several rinses with PBS, cells were
further incubated for 45 minutes with fluorescein conjugated
secondary antibody (goat antirabbit) in PBS.
Phosphotyrosine analysis
FAK immunoprecipitation and immunoblotting for FAK and
phosphotyrosine were done according to previously published
protocols.23 Briefly, cells were ‘‘starved’’ of serum and amino
acids in Earle’s balanced salts solution for four hours. After
wounding, cell migration, and washing, 107 cells were
scraped in lysis buffer (150 mM NaCl, 0.1% NaN3, 50 mM
Tris HCl (pH 7.6), 2 mM Na orthovanadate, 2 mg/ml aproti-
nin, 2 mg/ml leupeptin, 2 mg/ml phenyl methyl sulphonyl
fluoride, 0.1% triton X-100, and 0.1% Na+ deoxycholate) at
4 C̊. Cell lysates were then clarified by centrifugation for
10 minutes at 15 000 g and lysate volumes were normalised
for protein content. The supernatants were incubated with
anti-FAK antibody (Upstate Biotechnology) at 4 C̊ for a
minimum of 90 minutes. Rabbit antimouse IgG (Jackson
ImmunoResearch, West Grove, Pennsylvania, USA) bound to
protein A sepharose was then added and incubated with
mixing for a minimum of 90 minutes at 4 C̊. Beads were
sedimented and washed extensively with lysis buffer.
Proteins were then released for sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and blot
analysis by boiling in Laemmli sample buffer with 1 mM
Na orthovanadate for three minutes. Samples were electro-
phoresed on 8% SDS-PAGE and transferred to nitrocellulose.
After blocking with 1% bovine serum albumin in Tris
buffered saline with 0.05% Tween-20 for one hour, mem-
branes were incubated with horseradish peroxidase conju-
gated PY20 (ICN Biochemicals Inc., Costa Mesa, California,
USA) for one hour and developed using enhanced chemilu-
minescence (Amersham Corp., Arlington Heights, Illinois,
USA). After stripping of the antiphosphotyrosine antibody
with 100 mM b-mercaptoethanol and 0.2% SDS in 62.5 mM
Tris-HCl, pH 6.7, the membrane was washed and then
blocked with 5% dry milk in Tris buffered saline with
0.05% Tween-20 for one hour. Anti-FAK immunoblotting
was then accomplished using the anti-FAK antibody, horse-
radish peroxidase conjugated antimouse IgG secondary
antibody, and enhanced chemiluminescence.
Adenoviral transfection of IEC-6 cells
Ad5FAK-CD contains a dominant negative version of FAK
lacking the N terminus and the kinase domain.24 Ad5Luc
contains the luciferase reporter gene 59 of the adenovirus
promoter and was used as a control virus. IEC-6 cells, after a
24 hour period of culture in DMEM with 0.5% serum, were
infected with Ad5FAK-CD or Ad5Luc at a multiplicity of
infection of 500 for 12 hours in DMEM with 10% fetal bovine
serum (FBS). The infection medium was changed to fresh
0.2% FBS medium, and cells were incubated for an additional
24 hours. The efficiency of viral transfection was assessed
using an antibody directed to the carboxy terminus of FAK
(antibody 5158, produced by L Romer). Western blots of
Ad5FAK-CD transfected cells revealed a dense band at a
molecular weight of 42–44 kDa, indicating expression of
FAK-CD. There was no FAK immunoreactive band at a
molecular weight of 45 kDa in control cells.
Statistics
Results in the text and figures are expressed as mean (SEM).
Statistical significance of differences (p(0.05) between
mean values was assessed with one way ANOVA and a post
hoc Tukey’s test. For analysis of additivity of ARG and BSC,
we used a regression model with surface area of cell
migration as the response and variables ARG, BSC, and
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ARG+BSC interaction. The software program used was
SigmaStat (Jandel Scientific, San Rafael, California, USA).
RESULTS
ARG increased cell migration
IPEC-J2 and Cdx2 cell migration was enhanced by ARG after
razor wounding in a dose dependent manner (fig 1).
Maximal stimulation of migration by ARG was seen with
4 mM ARG, producing a 1.67-fold increase in surface area
covered. Arginine stimulated migration as effectively as any
other agonist tested, including 100 ng/ml epidermal growth
factor (47% enhancement); 1% fetal calf serum (55%
enhancement), and prostacyclin (1 mM) (25% enhance-
ment). Significant stimulation (p(0.05) was observed at
an ARG concentration as low as 2 mM. Maximal effect was at
4 mM, with diminishing results above 20 mM ARG. Similar
stimulatory effects of ARG on migration rate were observed
with untransformed IEC-6 cells (data not shown).
ARG was compared with five other amino acids with
respect to stimulation of cell migration. Glutamate, leucine,
phenylalanine, proline, and citrulline did not significantly
stimulate migration. L-Glutamine produced 46% enhance-
ment and was the only amino acid comparable to ARG. ARG
in these comparative studies with other amino acids
stimulated migration 1.7-fold (p(0.05) (n = 3).
ARG stimulated migration is associated with
increased tyrosine phosphorylation of FAK
To determine if increased tyrosine phosphorylation is




































Figure 1 (A) Enhancement of IPEC-J2 cell and Cdx2-IEC-6 cell
migration by arginine (ARG): dose response. Cells were serum starved
overnight and then changed to Dulbecco’s modified Eagle’s medium
(DMEM) with different concentrations of ARG (with no serum) one hour
prior to wounding. Cells were incubated in DMEM, and additional ARG
was added after wounding (DMEM without supplemental ARG contains
0.4 mM ARG.) After migration, cells were fixed in 2% formaldehyde in
phosphate buffered saline. Surface area covered by migrating cells was
measured 18 hours later for IPEC-J2 cells and six hours later for Cdx2
transformed IEC-6 cells. Computer assisted morphometry allowed
quantitation of the area covered in front of a 1 mm wound at 406
magnification. Shown are means (SEM) of four experiments, with
triplicate measurements for each experiment. Data were normalised for
control cells with 0 mM ARG added to media. (Surface area of migration
for IPEC-J2 cells with 0 mM added ARG was 132 (7) mm2/mm/24 hours
and for Cdx2 transformed IEC-6 cells was 48 (5) mm2/mm/6 hours.
Assuming linear rates of migration after wounding, our data indicate
that Cdx2 transformed IEC-6 cells migrate 1.5-fold faster than IPEC-J2
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Figure 2 Relationship between tyrosine phosphorylation, phosphorylation of focal adhesion kinase (FAK), and intestinal cell migration. (A) Tyrosine
kinase inhibitors inhibited cell migration. Tyrosine kinase inhibitors were added to IPEC-J2 cells 30 minutes before wounding with a razor (AG216
denotes tyrphostin). Surface area of migration was measured as described in figure 1, 24 hours after wounding; n = 3, *p(0.02 compared with
L-arginine (ARG) treated cells. For control (CTL)+AG216 treated cells, surface area migrated was marginally less than in CTL cells (p = 0.082).(B) ARG
enhanced phosphorylation of FAK: effect of ARG dose and time after wounding. Cdx2 cells were starved with Dulbecco’s modified Eagle’s medium
(DMEM) containing no serum and ARG overnight. Then, one hour before wounding, different doses of ARG were added to ARG-free DMEM. Cells
were wounded and harvested at 1, 4, and 8 hours after wounding. They were immunoprecipitated with anti-FAK antibody and blotted with either
antiphosphotyrosine (PY-20, top) or with anti-FAK (to control for equal loading, bottom). ARG at 2 and 4 mM (but not 1 mM) stimulated phosphor-
ylation of FAK at 1, 4, and 8 hours after wounding, with a peak effect at 1 h (1.7 fold increase, n = 3 observations). NW, non-wounded. (C) ARG
enhanced phosphorylation of FAK: effect of ARG dose and time after wounding. Response of phosphorylated FAK-PY to ARG and time; mean (SEM)
values for n = 3 experiments. p(0.05 compared with unwounded control cells. (D) ARG (4 mM) stimulated phosphorylation of FAK at one hour after
wounding while 3,3-bis(aminoethyl)-1-hydroxy-2-oxo-1-triazene (Deta-NONOate 10 mM) and bovine serum concentrate (BSC 100 mg/100 ml)
stimulated phosphorylation of FAK by four hours. Cdx2 transformed IEC-6 cells were serum starved overnight and harvested, or switched to medium
(one hour before wounding) containing DMEM without ARG (wound), ARG, or BSC. Cells were multiply wounded with a pipette tip and were harvested
one or four hours later. They were immunoprecipitated (IP) with anti-FAK antibody and immunoblotted using either antiphosphotyrosine antibody
(PY-20) or anti-FAK (to ensure equal loading). Densitometry analysis revealed that relative to that of control unwounded cells, FAK phosphorylation
increased in wounded monolayers by twofold at one and four hours. Furthermore, ARG stimulated phosphorylation of FAK by threefold at one hour
and by sixfold at four hours. Deta-NONOate and BSC treated cells had identical phosphorylation as control wounded cells at one hour and 2.5-fold
increased phosphorylation of FAK at four hours.
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were wounded in the presence or absence of an inhibitor of
tyrosine kinases, tyrphostin (AG216). Cells were grown on
plastic because adhesion to exogenous matrix proteins
increases the activation of FAK.25 Cdx2 transformed IEC-6
cells treated with AG216 migrated at a rate that was ,80% of
normal (p = 0.08, n = 3). Cell monolayers were wounded and
incubated with control medium or ARG¡AG216. Response
to ARG was inhibited by addition of AG216 to ,75% of that
of ARG treated cells (p(0.05) (fig 2). IPEC-J2 cellular
response to ARG was blocked by two other tyrosine kinase
inhibitors (herbimycin A 10 mM; tyrphostin 47 200 mM, data
not shown).
The effect of ARG on tyrosine phosphorylation of FAK was
determined by incubating cells with different concentrations
of ARG (0–4 mM) after razor wounding. FAK was immuno-
precipitated from lysates of each treatment group, and FAK
tyrosine phosphorylation was evaluated by western blotting.
ARG treatment after wounding increased tyrosine phosphor-
ylation of FAK at 1–4 hours post-wounding. The maximal
effect was seen with 2 mM ARG, which increased the
phosphotyrosine content of FAK 1.75 (0.2)-fold (p = 0.038,
n = 3) at one hour after wounding (fig 2B). Tyrphostin
AG216 markedly reduced ARG induced changes in FAK
phosphorylation (data not shown). Enhancement of FAK
activity by ARG persisted at four and eight hours (fig 2B, 2C).
The NO donor Deta-NONOate also stimulated FAK phos-
phorylation by 2.5-fold at four hours post-wounding (n = 3,
fig 2D).
Role of NO in ARG stimulated migration
We determined if ARG treatment enhanced nitrite levels in
the media as an index of NO production. Nitrite levels were
measured at 24 hours after injury. The ‘‘baseline’’ concentra-
tion of nitrite in the growth medium of normal unwounded
IPEC-J2 cells was 6.5 (0.5) mM at 24 hours after plating.
Multiple wounding resulted in an increase to 20 (1.4) mM
nitrite after 24 hours. Incubating cells with 4 mM ARG more
than doubled NO production to 47 (3.7) mM nitrite (p(0.05 v
control media containing 0.4 mM ARG) but BSC had no
stimulatory effect on nitrite level (24 (1.2) mM) (n = 4). ARG
(fig 3A) and Deta-NONOate (at 5–10 mM) increased nitrite
0 1 2
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Figure 3 (A) L-Arginine (ARG) dose dependently increased nitrite (NO) levels in media at 24 hours. Values are means (SEM), n = 4. **p(0.01
compared with control wounded cells. (B) Cell wounding enhanced the level of inducible nitric oxide synthase (iNOS). Cdx 2 transformed IEC-6 cells
were wounded multiple times with a plastic pipette tip and washed. At specified time intervals, cells were harvested and 100 mg protein were
electrophoresed and blotted with polyclonal anti-NOS II antibody. Densitometric analysis revealed maximal activation of iNOS by four hours. Results in
relative densitometric values were: non-wounded (NW) 16; wounded 0 min 1.76; wounded 30 minutes 4.76; wounded four hours 56; and wounded
24 hours 3.36. (C) Cell wounding enhanced cytoplasmic expression of iNOS at the leading edge. Immunocytochemical staining of Cdx-2 transformed
IEC-6 cells was preformed on unwounded and wounded cells. Weak cytoplasmic fluorescence in unwounded cells was transformed to bright
cytoplasmic fluorescence which was most evident in cells at the leading edge. Cells were stained and fixed at time points after wounding, as indicated.
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levels dose dependently. (Measurement of nitrite levels with
Deta-NONOate might not be accurate because the acidic
conditions of the Griess reaction induce NO release from NO
donors.)
Tissue injury is known to produce an increase in the level
of iNOS. To determine if cell injury induced expression of
iNOS, cells were multiply wounded and harvested at different
times after injury (fig 3B). The results indicated that iNOS
was expressed 1.8-fold at the time of wounding, 2.3-fold at
30 minutes after wounding, with a peak of 2.8-fold at four
hours, and reduced activation thereafter (fig 3B).
Immunofluorescence detection of iNOS in IPEC-J2 cells
(fig 3C) revealed a low baseline in unwounded resting
monolayers and in freshly wounded cells. A dramatic
increase in iNOS was seen in cells at the wound edge at
1–4 hours after wounding.
NMMA20 is an ARG analogue that competitively inhibits
NOS.13 We studied the effect of increasing concentrations of
NMMA on 2 mM ARG stimulated cell migration (fig 4A).
NMMA reduced ARG stimulated IPEC-J2 cell migration in a
dose dependent manner, with complete inhibition at 2 mM
NMMA. Individually given to IPEC-J2 cells in standard
media, NMMA did not inhibit the basal rate of migration
(data not shown, n = 4). NMMA completely blocked NO
synthesis from ARG in IPEC-J2 cells. NMMA fully inhibited
ARG stimulated nitrite production at 24 hours (wounded
control cells = 10.4 mM nitrite; wounded¡ARG (4 mM) =
25.7 mM nitrite; wounded¡ARG¡NMMA (4 mM) = 8.2 mM
nitrite; wounded¡NMMA = 4.6 mM nitrite).
Similar to NMMA, the specific inhibitor of iNOS, L-N6
(1-iminoethyl)lysine (L-Nil), inhibited ARG stimulated
migration at 5 mM (data not shown). These findings indicate
that NO production is essential for ARG stimulated migra-
tion. To further support this relationship, we demonstrated
that the NO donor Deta-NONOate individually stimulated
IPEC-J2 cell migration by 1.5-fold (data not shown). NMMA
inhibition of ARG stimulated migration could be ‘‘rescued’’
by administration of the NO donor Deta-NONOate (50 mM;
fig 4B). NMMA did not significantly affect BSC stimulated
cell migration (n = 3, data not shown).
Additive effects of ARG+BSC on enterocyte migration
BSC at 5 mg/ml stimulated cell migration 1.5 fold (p(0.05),
an effect comparable with that of 4 mM ARG. We could not
achieve saturation because of limiting solubility (5 mg/ml)
although stimulation with 5 mg/ml was not significantly
greater than that with 0.1 mg/ml. Figure 5 shows a
photomicrograph of migrating cells treated with ARG
(4 mM), BSC (0.1 mg/ml), or combinations of these treat-
ments. ARG plus BSC (‘‘A+B’’) increased IPEC-J2 cell
migration significantly more effectively than ARG or BSC
alone. In three experiments of 3–4 observations each, the
adjusted mean response of control cells was 60 (5) mm2/mm;
of ARG treated cells 88 (7) mm2/mm; of BSC treated cells 107
(6) mm2/mm; and of ARG+BSC treated cells 128 (6) mm2/mm
wound (p(0.001 for ARG+BSC compared with either ARG or
BSC).
ARG stimulated enterocyte migration is blocked by
ODC inhibition
ARG is a precursor of ornithine via the action of argi-
nase(s).26 27 Ornithine derived polyamines (putrescine (PUT),
spermidine, and spermine) are essential for intestinal cell
migration.28–30 We postulated that inhibition of ODC, the rate
controlling enzyme in polyamine biosynthesis, would abolish
stimulation of migration by ARG. The ODC inhibitor DFMO
was used at 5 mM, a concentration that was previously
shown to maximally inhibit ODC in the IPEC-J2 cell line.16
DFMO by itself did not inhibit basal levels of migration (113
(6) mm/mm v 106 (6) mm/mm in control cells). Failure of
DFMO to fully block migration is consistent with the
observation that after four days of DFMO, cellular spermine
levels remained 50% of normal.19 Figure 6A shows that ARG
stimulated migration was blocked by DFMO, and that PUT
rescued this DFMO effect.
High pressure liquid chromatography was used to deter-
mine if ARG treatment for 24 hours enhanced IPEC-J2 cell
polyamine levels. Figure 6B shows that addition of ARG did
not enhance polyamine levels. Serum induces ODC in
intestinal cells.16 BSC 100 mg/100 ml produced threefold
increases in the levels of PUT, spermidine, and spermine
(p(0.05). These levels were higher compared with those of
freshly isolated piglet enterocytes21 but were very similar to
those previously reported for cultured Cdx2 transformed
IEC-6 cells.19
In our additional studies, high dose PUT (0.1 mM) alone
did not significantly stimulate IPEC-J2 cell migration (data
not shown, n = 3). These results suggest that despite a
constitutive role of polyamines, the efficacy of ARG cannot be


























































































IPEC-J2 cell migration (µm2/µm)
IPEC-J2 cell migration (µm2/µm)
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ARG + NMMA +
DetaNONAte *
ARG + NMMA
ARG 4 mM *
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0 50 100 150 200
Figure 4 Effect of a nitric oxide synthase inhibitor on intestinal cell
migration. L-NG-monomethyl arginine (NMMA) was used to inhibit nitric
oxide synthases while 3,3-bis(aminoethyl)-1-hydroxy-2-oxo-1-triazene
(Deta-NONOate) (an NO donor) reversed the inhibition by NMMA.
(A) IPEC-J2 cells were serum starved for 24 hours and then changed to
Dulbecco’s modified Eagle’s medium with different doses of NMMA one
hour before adding 2 mM L-arginine (ARG). Subsequently, they were
injured by razor wounding. After 24 hours, cells were fixed and
migration was measured by computer assisted morphometry. ‘‘ARG 2’’
indicates 2 mM ARG; the number after NMMA indicates concentration
of NMMA (mM). Values are means (SEM) of three experiments. p(0.05
above migration in control cells (C). (B) Inhibition of ARG stimulated
migration by NMMA (4 mM) was ‘‘rescued’’ by simultaneous addition
of Deta-NONOate (10 mM). Cells were treated one hour before and
after wounding with NMMA (4 mM), ARG (4 mM), or ARG+NMMA
plus Deta-NONOate (10 mM) (n = 4). *p(0.05 compared with control
cells (CTL).
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Requirement for FAK in ARG stimulated enterocyte
migration: transfection studies
To determine if FAK phosphorylation is required for
intestinal cell migration and the response to ARG, Cdx-2
transformed IEC-6 cells were transfected with a dominant
negative construct of FAK mediated by adenoviral gene
transfer.24 Adenovirus promoter linked to luciferase was used
as a control for cells with intact FAK activity. Preliminary
studies showed that control cell infection for 12 hours led to
a steady rise in luciferase expression (n = 3). Therefore,
transfections were performed for 12 hours. FAK-CD transfec-
tion reduced basal cellular migration by 33% compared with
control virus and also fully inhibited the cell migration
response to ARG and BSC. In contrast, control transfection
with adeno-luciferase had no inhibitory effect on the ARG
response, with cells migrating at .26 the control rate after
treatment with either ARG or BSC (p(0.05) (fig 7).
DISCUSSION
Nitric oxide in cell migration
One of the most important metabolites of arginine is NO
which plays an important role in regulating intestinal barrier
function.13 In newborn pigs, pretreatment with intravenous
ARG greatly attenuated necrotising enterocolitis (NEC)
produced by intraluminal acidified casein31 and improved
intestinal recovery after ischaemic damage in rats by an NOS
dependent mechanism.9 10 Our finding that NO stimulates
post-injury intestinal epithelial cell migration is consistent
with several studies in other cell types. ARG, NO donors, and
NO second messengers enhanced endothelial cell migra-
tion.11 32 NO was reported to inhibit cell adhesion to matrix
(and activation of FAK) in renal mesangial cells, vascular
smooth muscle cells, and endothelial cells.33–35 In normal
renal epithelial monolayers, after wounding there is a
biphasic release of NO during cell migration with peaks at
1–2 minutes and again after 2–3 hours. This NO release is
accompanied by iNOS expression at the wound edge.11 32 It
has been suggested that increased NO facilitates detachment
and scalar movement, as opposed to vectorial movement.32
Arginine stimulated cell migration was dose dependent,
with a maximal effect at 4 mM. Required doses were
therefore .40-fold higher than serum levels in preterm
infants (94 (10) mM)36 and in porcine milk (65 (5) mM).37
However, ARG concentrations in the intestine secondary to
postprandial luminal proteolysis can be much higher—in the
range 1–2 mM21 37—and thus our findings are physiologically
relevant. We recently showed that ARG stimulates restitution
of injured intestinal epithelial sheets. Gookin et al showed
that the iNOS specific inhibitor L-Nil is effective in blocking
ARG plus serum stimulated migration in the injured piglet
ileum.38 At supraphysiological levels (.20 mM), ARG effi-
cacy was abolished. Although not explored, this inhibition
could be secondary to inhibitory effects of high dose NO.
FAK as a signalling molecule in intestinal cell
migration
Previous studies demonstrated a central role for FAK in cell
migration in mesenchymal cells, such as human umbilical
vein endothelial cells. Tyrosine phosphorylation of FAK
correlated well with FAK activation and motility while a
tyrosine kinase inhibitor blocked migration and FAK activa-
tion.3 23 Overexpression of FAK increased cell migration.39 In
research focusing on intestinal cells, Caco-2 cell adhesion to
laminin or type I collagen was shown to require tyrosine
phosphorylation.25 Inhibition of FAK tyrosine phosphoryla-
tion (by transfection with FAK related non-kinase) blocked
adhesion, extracellular related kinase activation,25 and cell
migration.40
Our studies support a primary role for FAK in ARG
stimulated small intestinal cell migration. ARG increased
Control ARG
BSC A+B
Figure 5 Additive stimulation of IPEC-J2 cell migration by L-arginine (ARG) and bovine serum concentrate (BSC). Twenty four hour serum starved cells
were changed to Dulbecco’s modified Eagle’s medium without additives (control) or with one of the following: 4 mM ARG (‘‘A’’); 0.1 mg/ml BSC alone
(‘‘B’’); or ARG+BSC (‘‘A+B’’), added to cells one hour prior to wounding. After 24 hours, cells were fixed in 2% formaldehyde/phosphate buffered
saline, and migration area was measured as described above. The photomicrograph represents one of six experiments in which ARG and BSC were
compared with ARG+BSC. The razor scratch line is enhanced with a black line.
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FAK tyrosine phosphorylation at early time points, with a
dose dependent response in the same range that stimulates
migration. Blocking FAK localisation and function by
adenoviral infection with a dominant negative mutant
blocked ARG stimulation. We suggest that FAK activation
is an essential mechanism of ARG stimulated cell migration.
Although cells can migrate in the absence of functional FAK,
they do so less efficiently (fig 7), as has been demonstrated in
mouse embryo fibroblasts from FAK null animals.41
Downstream targets that are effectors have been shown to
bind to FAK and are activated by FAK.39 We hypothesise, as
summarised in fig 8, that FAK activation in response to ARG,
NO, or BSC enhances intestinal cell motility in a causal
fashion. In this diagram, we propose that ARG not only
enhances the synthesis of NO, which can stimulate FAK
phosphorylation (fig 2), but may also stimulate FAK
independently of NO. Consistent with this suggestion is our
finding that ARG activates FAK phosphorylation at the one
hour time point to a greater extent than the NO donor. Other
investigators have also shown that the NO donor sodium
nitroprusside mimics the effects of ARG on human umbilical
vein endothelial cell migration and FAK phosphorylation,
albeit with a different time course.42 Finally, NO can directly
stimulate cell migration and FAK phosphorylation (fig 8).
Requirement for polyamines in intestinal cell
migration
Polyamines (PUT, spermidine, and spermine) are central to
the restitution process in intestinal tissues.28-30 Their synthesis
from precursors such as ARG is required for migration, and
inhibition of migration by the ODC inhibitor DFMO can be
‘‘rescued’’ by the exogenous polyamine PUT (fig 6A), via its
conversion to spermine.43 Of interest, FAK signalling,
including phosphorylation of paxillin, has been found to be
dependent on polyamines.43 Polyamines are constitutively
required for the stimulatory effect of ARG. However,
polyamines can stimulate cell matrix adhesion, as proposed
in fig 8. Santos et al showed that polyamine deficiency
inhibited cell attachment to plastic, laminin, fibronectin,
collagen IV, and Matrigel by different extents. Polyamines
were essential for normal expression of the integrin subunit
a2 but not for expression of the a1 subunit. Thus polyamines
participate in cell attachment and expression of the integrin
a2 b1, a putative receptor for collagen and laminin.44
We have shown in this study that increasing ARG levels
above the basal medium concentration of 0.4 mM did not




































































NW PUT 0.13 (0.04) nmol/mg protein
NW SPD 2.6 (0.9) nmol/mg protein
NW SPM 4.5 (0.9) nmol/mg protein
A
B
Figure 6 Relationship between polyamine synthesis and cell migration
in response to L-arginine (ARG). The inhibitor difluoromethyl-ornithine
(DFMO 1 mM) was added 24 hours before the treatment of ARG
(4 mM). (A) ARG (4 mM) stimulated migration was blocked by DFMO
(1 mM), and was ‘‘rescued’’ by putrescine (PUT 100 mM); n = 4,
*p(0.05. (B) Effects of ARG (4 mM) on IPEC-J2 cellular polyamine
levels. Bovine serum concentrate (BSC) (100 mg/100 ml), which
induced ornithine decarboxylase, is used as a positive control.
Intracellular polyamine concentration was determined 24 hours after
wounding, as described in the methods section. BSC significantly
increased PUT, spermidine (SPD), and spermine (SPM) levels. Cellular
polyamine levels are shown at the bottom for non-wounded (NW) cells.
Bars refer to levels compared with non-wounded cells. Values are means





































Figure 7 Cells transfected with a dominant negative version of focal
adhesion kinase (FAK) do not have increased migration in response to
L-arginine (ARG) or bovine serum concentrate (BSC). Cdx2 transformed
IEC-6 cells were transfected (12 hours) with adeno-FAK-CD (DN denotes
dominant negative) or adeno-luciferase (Adeno-Luc). Subsequently,
monolayers were wounded in the presence of control media (ARG
0.4 mM), media+ARG (4 mM), or media+BSC (0.1 mg/ml). Surface
area covered by migrating cells was measured 12 hours later. *p(0.05














Figure 8 Schematic showing proposed mechanisms of L-arginine
(ARG), nitric oxide, and bovine serum concentrate (BSC) additivity in
intestinal cell migration. Focal adhesion kinase (FAK) is seen as an
integrative point of convergence leading to increased cell matrix
adhesion dynamics. Polyamines are required for this process but only
BSC results in increased polyamine synthesis.
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increase polyamine synthesis, consistent with studies in
cultured smooth muscle cells and endothelial cells.45–47 These
findings may indicate that arginase rather than arginine
levels limits the production of polyamines in cultured
intestinal cells, as recently reported for cultured endothelial
cells.48
Clinical implications of ARG in paediatric intestinal
disease
ARG metabolism is of major importance to neonatal
nutrition.12 49 ARG serum levels dwindle below normal levels
in preterm infants that later develop NEC, and these levels
are in the range of 0.04–0.06 mM, well below postprandial
luminal levels (see above) and below the maximal levels to
stimulate intestinal cell migration shown in these studies.36 50
A recent prospective controlled trial of ARG versus non-
essential amino acid therapy for preterm infants showed that
ARG supplementation significantly reduced the incidence of
NEC.51 Our investigations have identified the cellular
mechanism of a restitution enhancing effect of ARG. Our
studies show that the magnitude of ARG stimulated cell
migration equals that of growth factors and prostaglandins.
Further defining the role of ARG in restitution may provide a
rationale for administering exogenous free ARG and BSC (or
components of BSC) in treatment solutions for patients with
intestinal injury.
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